The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU

Ankara City Hospital Bilkent158 enrolled

Overview

Aim of the study is to determinate the frequency of acute renal failure in COVID-19 patients, its relationship with the severity of COVID-19 disease in ICU, and the ability to take precautions against these factors.

Study Type

OBSERVATIONAL

Enrollment

158

Conditions

COVID19 Acute Renal Failure

Interventions

BRESCİA-COVİD Respiratory Severity ScaleOTHER

KDIGO acute renal failure score BRESCİA-COVID Respiratory Severity Score

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Patients hospitalized in the intensive care unit diagnosed with COVID-19 will include in the study. Exclusion Criteria: there is no exclusion criteria

Locations (1)

Ankara City Hospital

Ankara, Turkey (Türkiye)

Outcomes

Primary Outcomes

KDIGO criteria

KDIGO Criteria stage 1: Increase in SCr by ≥ 0.3 mg/dL within 48 hours or increase in SCr 1.5 to 1.9 times baseline which is known or presumed to have occurred within the prior 7 days Stage 2: 2.0 to 2.9 multiplied by baseline SCr; Stage 3: 3.0 or more multiplied by baseline; increase in SCr ≥ 4.0 mg/dL; or beginning of renal replacement therapy regardless of a previous KDIGO stage.

Time frame: 6 months

BRESCIA-COVID RESPIRATORY SEVERITY SCALE (BCRSS) scores

The BCRSS score (between level 0-8) is calculated from "www.mdcalc.com/brescia-covid-respiratory-severity-scale-bcrss-algorithm" according to the severity of COVID disease , respiratory rate, PaO2 level, chest x-ray, and clinical status.

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.